financetom
Business
financetom
/
Business
/
--Merck to Discontinue Phase 3 Lung Cancer Drug Trial on Committee's Recommendation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Merck to Discontinue Phase 3 Lung Cancer Drug Trial on Committee's Recommendation
Aug 8, 2024 4:08 AM

06:58 AM EDT, 08/08/2024 (MT Newswires) --

Price: 112.05, Change: -0.44, Percent Change: -0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved